Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Berkeley Heights, New Jersey--(Newsfile Corp. - November 24, 2025) - Kalaris Therapeutics, Inc. (Nasdaq: KLRS) ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced that management will present at the upcoming Noble Capital Markets 21st Annual Emerging Growth Equity Conference.Details:Type: Company presentationSpeakers: Matthew Feinsod, Chief Medical Officer Date: Wednesday, December 3, 2025Ti ...